UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials
Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology.
(Carolina Alumni Review)
Related: Campus Connections
William Leuchtenburg, UNC professor emeritus, eminent historian & Ken Burns consultant, dies at 102William Leuchtenburg, a prize-winning historian widely admired for his authoritative writings on the U.S. presidency and as the reigning scholar on Franklin Roosevelt and the...
Thu Jan 30, 2025Morehead Planetarium nominated in national contest
A planetarium in North Carolina has been nominated for Best Planetarium by USA Today’s Readers’ Choice 2025. Morehead Planetarium in Chapel Hill is currently in...
Wed Jan 29, 2025
Shrunken Head Boutique sees Bill Belichik hiring as a win for their business
Employees at The Shrunken Head say former NFL head coach and eight-time Super Bowl champion Bill Belichick will bring wins on the field and in...
Mon Jan 27, 2025
Carolina selected for Mental Health Services Honor Roll
UNC’s abundance of resources supporting student mental health and well-being services has received recognition from The Princeton Review’s inaugural mental health services honor roll, landing...
Sun Jan 26, 2025